Wednesday's mass shooting at a Tulsa hospital campus marks the 233rd mass shooting in the U.S. this year. Healthcare workers across the country are arguing that the nation's gun violence problem should be treated as a public health crisis and met with legislative reform.
Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and helps improve the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.
To learn more about AccuRhythm AIPlatform, please click here to the download an infographic explaining how it works.
By Smriti Kirubanandan Friday, June 3, 2022 6:25 PM
Food is one of the fundamental blocks for our survival and has a significant impact on our mental and physical health. An alarming 38 million Americans live in food-insecure households.
Bristol Myers Squibb is splashing out $4.1 billion to acquire Turning Point Therapeutics, a clinical-stage biotech whose lead drug is currently in pivotal testing as a treatment for certain lung cancers. Recently reported preliminary data suggest the small molecule could have advantages over currently available drugs in the same class from rivals Pfizer and Roche.
RPM as we know it today – with all its advantages – falls short. The reason? Monitoring and alerting alone cannot provide one of the most critical parts of healthcare: care itself.
No comments